Abstract:The gut microbiome has emerged as an important factor affecting human health and disease. The recent development of –omics approaches, including phylogenetic marker-based microbiome profiling, shotgun metagenomics, metatranscriptomics, metaproteomics, and metabolomics, has enabled efficient characterization of microbial communities. These techniques can provide strain-level taxonomic resolution of the taxa present in microbiomes, assess the potential functions encoded by the microbial community and quantify the metabolic activities occurring within a complex microbiome. The application of these meta-omics approaches to clinical samples has identified microbial species, metabolic pathways, and metabolites that are associated with the development and treatment of human diseases. These findings have further facilitated microbiome-targeted drug discovery and efforts to improve human health management. Recent in vitro and in vivo investigations have uncovered the presence of extensive drug-microbiome interactions. These interactions have also been shown to be important contributors to the disparate patient responses to treatment that are often observed during disease therapy. Therefore, developing techniques or frameworks that enable rapid screening, detailed evaluation, and accurate prediction of drug/host-microbiome interactions is critically important in the modern era of microbiome research and precision medicine. Here we review the current status of meta-omics techniques, including integrative multi-omics approaches, for characterizing the microbiome's functionality in the context of health and disease. We also summarize and discuss new frameworks for applying meta-omics approaches and microbiome assays to study drug-microbiome interactions. Lastly, we discuss and exemplify strategies for implementing microbiome-based precision medicines using these meta-omics approaches and high throughput microbiome assays.

Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.

Metabolome analysis for investigating host-gut microbiota interactions

Metabolomics: Towards Understanding Host-Microbe Interactions.

Metabolomic Applications in Gut Microbiota-Host Interactions in Human Diseases

Metabolite interactions between host and microbiota during health and disease: Which feeds the other?

Host and Microbiome Multi-Omics Integration: Applications and Methodologies.

Messengers From the Gut: Gut Microbiota-Derived Metabolites on Host Regulation

Gut microbial metabolites as multi-kingdom intermediates

Metabonomic Phenotyping for the Gut Microbiota and Mammal Interactions

The Role of Gut Microbiota Associated Metabolites in Digestive Disorders

Co-metabolism: vital interactions between mammals and symbiotic gut microbiota

The effect of intestinal flora involved in host metabolism on personal health care

Metabolites: a converging node of host and microbe to explain meta-organism

Small molecules in the big picture of gut microbiome-host cross-talk

FROM MICROBIOME TO METABOLOME

An overview of host‐derived molecules that interact with gut microbiota

Advances in the integration of metabolomics and metagenomics for human gut microbiome and their clinical applications

Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health

Emerging Targetome and Signalome Landscape of Gut Microbial Metabolites

Advancing functional and translational microbiome research using meta-omics approaches

Using Metabolomics to Analyse the Role of Gut Microbiota in Nutrition and Disease